Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear

Jul.17.2025
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.

Key Points:

 

·A study in Australia has found that the success rate of quitting smoking using e-cigarettes is three times higher than traditional nicotine replacement therapy.

 

·The study involved over 1000 smokers, with 28% of the e-cigarette group remaining smoke-free after six months, compared to less than 10% in the traditional therapy group. 

 

·The study emphasizes the short-term effectiveness of e-cigarettes, but further research is needed to understand their long-term health impacts.

 


【2Firsts News Flash】According to a report by UPI on July 14th, a new Australian study suggests that e-cigarettes may be more effective in helping people quit smoking compared to traditional nicotine replacement therapy.

 

Researchers reported in the Annals of Internal Medicine that individuals using flavored e-cigarette devices containing nicotine had a three times higher smoking cessation rate within six months compared to those using nicotine gum or lozenges.

 

“Nicotine vapor products are more effective in smoking cessation compared to nicotine replacement therapy.”

 

The research team led by Associate Professor Ryan Courtney of the National Drug and Alcohol Research Centre at the University of New South Wales in Australia wrote.

 

In order to conduct this study, researchers recruited over 1000 Australians receiving government assistance and randomly assigned them to either the e-cigarette group or the nicotine replacement group. All participants were interested in trying to quit smoking.

 

The e-cigarette group received an eight-week supply of tobacco, mint, or fruit flavored e-liquid, while the nicotine replacement group opted for an eight-week supply of gum or lozenges.

 

Researchers stated that all participants also received automated text messages for five weeks, which provided them with behavioral support for their smoking cessation attempts.

 

A study found that after six months, over 28% of individuals in the e-cigarette group remained smoke-free, while slightly less than 10% of individuals in the nicotine gum or lozenge group remained smoke-free.

 

“In the current trial, it was found that for disadvantaged populations, flavored nicotine vaping products combined with minimal text-based support were more effective than nicotine replacement therapy gum or lozenges.”

 

Researchers have reached a conclusion.

 

However, researchers point out that further research is needed to ensure that people can maintain a smoke-free status in the long term when using e-cigarette devices.

 

Researchers added that it is still not clear whether people are simply replacing one health risk with another.

 

“Despite current evidence suggesting that switching completely from smoking cigarettes to e-cigarettes can reduce health risks, the long-term health effects of e-cigarettes are largely unknown, and there is data indicating that e-cigarettes may impact cardiovascular health.”

 

The researchers wrote.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
Russian Police Seize Over 150,000 Counterfeit E-Cigarettes Worth More Than USD 1.65 Million
Russian Police Seize Over 150,000 Counterfeit E-Cigarettes Worth More Than USD 1.65 Million
Russian police in Tambov have detained a man for storing and selling unmarked e-cigarettes. Over 150,000 counterfeit e-cigarettes, cartridges, and e-liquids were seized, valued at more than 126.5 million rubles (approximately USD 1.65 million). Tests revealed that the nicotine content of the seized products exceeded the levels stated on their packaging. A criminal case has been opened under Article 171.1, Part 6 of the Russian Criminal Code.
Dec.09 by 2FIRSTS.ai
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
Sarawak Cabinet Approves Gradual Ban on Vape Products to Curb Rising Youth Use
The Sarawak Cabinet has agreed to implement a phased ban on vape products amid growing concern over rising use among youths. Welfare, Community Wellbeing, Women, Family and Childhood Development Minister Datuk Seri Fatimah Abdullah said the move demonstrates the state’s firm commitment to safeguarding young people’s health and future.
Nov.17 by 2FIRSTS.ai
Belarus to Tighten Vape Regulations, Raise Excise Taxes in 2026
Belarus to Tighten Vape Regulations, Raise Excise Taxes in 2026
Belarusian lawmakers are drafting a new bill to regulate the vape market amid growing concern over youth nicotine use and the spread of illegal products. While a total ban is not planned, the focus will be on stricter licensing, advertising limits, and higher taxes.
Nov.19 by 2FIRSTS.ai
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
The vaping brand OXBAR has recently listed its open-system, refillable pod device OX35K on its official website. The product features a “2ml built-in pod + two 10ml external refill bottles” e-liquid supply structure and supports top refilling, with a claimed puff count of up to 35,000. It is equipped with a 1000mAh built-in battery and offers dual power modes—BOOST and ECO—positioning the device to balance high-puff performance with an open-system form factor.
Jan.13 by 2FIRSTS.ai
UPC Court of Appeal refuses to revive VMR’s European vape patent, upholding lack of inventiveness
UPC Court of Appeal refuses to revive VMR’s European vape patent, upholding lack of inventiveness
The Unified Patent Court’s Court of Appeal declined on Dec. 29 to revive a European patent held by VMR Products LLC, upholding a finding that the patent is not inventive over earlier devices. The decision said adding a window in the vape’s outer shell to reveal the internal cartridge holding vape liquid was an obvious, routine adaptation based on an earlier U.S. patent and general knowledge.
Jan.06 by 2FIRSTS.ai